Douglas K. Ammerman
Douglas K. Ammerman's purchase track record
Douglas K. Ammerman has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/8/2023 | FG | $202K | +66.6% | +94.3% | +5.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RBC Capital Upgrades Cannae Holdings, Raises Target to $17. RBC Capital has kept its outperform rating for Cannae Holdings and lifted its price target to $17. The new target sits close to the current analyst average of $17.25. The stock is trading above its $15.36 support level and has a moderate RSI of 58.9, indicating no immediate overbought pressure.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
FNF and Title Insurance Peers See Price Declines Amid Sector Trends. Fidelity National Financial shares recently declined alongside other major title insurance firms like Radian Group and First American Financial. This movement occurred within a broader sector trend where these stocks traded down together. The company currently offers a dividend yield of 4.27%, which may be a factor for income-focused observers monitoring the stock's recent price action.
Transaction History
| FG | ▲ Buy | Grant | 1,013 | $22K | 10/1/2026 | View on chart |
| CNNE | ▲ Buy | Grant | 2,853 | $44K | 9/30/2026 | View on chart |
| FG | ▲ Buy | Grant | 816 | $0 | 7/1/2026 | View on chart |
| CNNE | ▲ Buy | Grant | 3,039 | $44K | 6/30/2026 | View on chart |
| FG | ▲ Buy | Grant | 863 | $0 | 4/1/2026 | View on chart |
| CNNE | ▲ Buy | Grant | 3,848 | $44K | 3/31/2026 | View on chart |
| FG | ▲ Buy | Grant | 762 | $0 | 1/5/2026 | View on chart |
| FG | ▼ Sell | Other | 8,298 | $256K | 12/31/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 2,782 | $44K | 12/31/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 23,453 | $0 | 11/12/2025 | View on chart |
| FG | ▲ Buy | Grant | 6,436 | $0 | 11/10/2025 | View on chart |
| FNF | ▲ Buy | Grant | 4,870 | $0 | 11/10/2025 | View on chart |
| FG | ▲ Buy | Grant | 722 | $0 | 10/1/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 3,140 | $57K | 9/30/2025 | View on chart |
| FG | ▲ Buy | Grant | 684 | $0 | 7/1/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 900 | $19K | 6/30/2025 | View on chart |
| FG | ▲ Buy | Grant | 604 | $0 | 4/1/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 1,023 | $19K | 3/31/2025 | View on chart |
| FG | ▲ Buy | Grant | 1,017 | $42K | 1/6/2025 | View on chart |
| CNNE | ▲ Buy | Grant | 1,889 | $38K | 12/31/2024 | View on chart |
| CNNE | ▲ Buy | Grant | 6,119 | $0 | 11/14/2024 | View on chart |
| FNF | ▲ Buy | Grant | 6,310 | $0 | 11/8/2024 | View on chart |
| FG | ▲ Buy | Grant | 6,515 | $0 | 11/8/2024 | View on chart |
| FG | ▲ Buy | Grant | 908 | $38K | 10/1/2024 | View on chart |
| CNNE | ▲ Buy | Grant | 1,968 | $38K | 9/30/2024 | View on chart |
| FG | ▲ Buy | Grant | 1,015 | $38K | 7/1/2024 | View on chart |
| CNNE | ▲ Buy | Grant | 2,068 | $38K | 6/28/2024 | View on chart |
| FG | ▲ Buy | Grant | 946 | $38K | 4/1/2024 | View on chart |
| CNNE | ▲ Buy | Grant | 550 | $12K | 3/29/2024 | View on chart |
| CNNE | ▲ Buy | Grant | 3,473 | $0 | 2/28/2024 | View on chart |
| FNF | ▲ Buy | Grant | 6,301 | $0 | 11/15/2023 | View on chart |
| FG | ▲ Buy | Grant | 5,172 | $0 | 11/15/2023 | View on chart |
| FG | ▲ Buy | Open Market | 12,004 | $202K | 5/8/2023 | View on chart |
| FG | ▲ Buy | Grant | 827 | — | 12/1/2022 | View on chart |
| FG | ▲ Buy | Grant | 9,175 | $0 | 12/1/2022 | View on chart |
| FNF | ▲ Buy | Grant | 6,491 | $0 | 11/10/2022 | View on chart |
| FNF | ▲ Buy | Grant | 5,144 | $0 | 11/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
F&G Annuities lowers Q3 investment income estimates
F&G Annuities & Life provided a preliminary estimate for Q3 2026 investment income from alternative investments, projecting $47M to $57M pre-tax. This figure is below the company's expected return, signaling potential pressure on earnings. The stock is currently trading near its 52-week low, reflecting broader market concerns about higher Treasury yields impacting the life insurance sector.
F&G Annuities lowers Q3 investment income estimates. F&G Annuities & Life provided a preliminary estimate for Q3 2026 investment income from alternative investments, projecting $47M to $57M pre-tax. This figure is below the company's expected return, signaling potential pressure on earnings. The stock is currently trading near its 52-week low, reflecting broader market concerns about higher Treasury yields impacting the life insurance sector.